Page last updated: 2024-10-29

ketamine and Weight Gain

ketamine has been researched along with Weight Gain in 6 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research Excerpts

ExcerptRelevanceReference
"Ketamine groups showed a decreased evolution in body weight gains during the treatment period."3.79Chronic ketamine administration impairs mitochondrial complex I in the rat liver. ( Antunes, L; Félix, L; Peixoto, F; Rodrigues, P; Summavielle, T; Venâncio, C, 2013)
"Ketamine-treated mice showed cell degeneration mainly in the parietal cortex, whereas the Ethanol-High mice showed marked cell degeneration in both the parietal and laterodorsal cortex."1.32Hyperactivity following postnatal NMDA antagonist treatment: reversal by D-amphetamine. ( Archer, T; Fredriksson, A, 2003)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Moraga-Amaro, R1
Guerrin, CGJ1
Reali Nazario, L1
Lima Giacobbo, B1
J O Dierckx, RA1
Stehberg, J1
de Vries, EFJ1
Doorduin, J1
Venâncio, C1
Antunes, L1
Félix, L1
Rodrigues, P1
Summavielle, T1
Peixoto, F1
Sun, L1
Li, Q2
Zhang, Y1
Liu, D1
Jiang, H1
Pan, F1
Yew, DT1
Fredriksson, A2
Archer, T2
Danneman, PJ1
Mandrell, TD1

Other Studies

6 other studies available for ketamine and Weight Gain

ArticleYear
A single dose of ketamine cannot prevent protracted stress-induced anhedonia and neuroinflammation in rats.
    Stress (Amsterdam, Netherlands), 2022, Volume: 25, Issue:1

    Topics: Anhedonia; Animals; Antidepressive Agents; Carrier Proteins; Corticosterone; Depression; Disease Mod

2022
Chronic ketamine administration impairs mitochondrial complex I in the rat liver.
    Life sciences, 2013, Oct-06, Volume: 93, Issue:12-14

    Topics: Analgesics; Animals; Electron Transport Complex I; Glycogen; Ketamine; Liver; Male; Mitochondria, Li

2013
Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeys.
    Addiction biology, 2014, Volume: 19, Issue:2

    Topics: Adolescent; Analysis of Variance; Animals; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal;

2014
Hyperactivity following postnatal NMDA antagonist treatment: reversal by D-amphetamine.
    Neurotoxicity research, 2003, Volume: 5, Issue:7

    Topics: Animals; Behavior, Animal; Brain; Central Nervous System Depressants; Central Nervous System Stimula

2003
Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD.
    Neurotoxicity research, 2004, Volume: 6, Issue:6

    Topics: Animals; Animals, Newborn; Apoptosis; Attention Deficit Disorder with Hyperactivity; Central Nervous

2004
Evaluation of five agents/methods for anesthesia of neonatal rats.
    Laboratory animal science, 1997, Volume: 47, Issue:4

    Topics: Anesthesia, General; Anesthetics; Animals; Animals, Newborn; Droperidol; Drug Evaluation; Female; Fe

1997